Document Detail

beta-catenin expression and mutational analysis in renal cell carcinomas.
MedLine Citation:
PMID:  11012986     Owner:  NLM     Status:  MEDLINE    
beta-Catenin acts as a downstream transcriptional activator of the Wingless-Wnt signaling pathway. The beta-catenin-Tcf complex transactivates the downstream genes that regulate cell proliferation or inhibit apoptosis. The activation of this pathway through stabilization of beta-catenin is caused either by inactivating mutations of adenomatous polyposis coli (APC) tumor suppressor gene or by activating mutations in beta-catenin exon 3. To determine whether the abnormal expression and activating mutations in exon 3 of the beta-catenin gene are implicated in renal cell carcinogenesis, 52 renal cell carcinomas (RCC) were analyzed by immunohistochemistry, polymerase chain reaction-single-strand conformational polymorphism analysis (PCR-SSCP), and direct DNA sequencing. Immunohistochemically, all cases, as well as normal kidneys, showed membranous and/or cytoplasmic staining patterns without nuclear localization. However, the cytoplasmic accumulations of beta-catenin were observed in five (22.7%) of 22 cases of conventional (clear cell) renal carcinoma, but not in papillary or chromophobe renal carcinomas. The beta-catenin mutation was identified in only one case of conventional renal carcinoma and was a single-base missense mutation on codon 61, leading to substitution of glutamine by arginine. In conclusion, this study demonstrates that beta-catenin mutations are a relatively rare event in RCC and that cytoplasmic accumulations of beta-catenin protein are found only in conventional (clear cell) renal carcinomas. These data suggest that the activation of the beta-catenin signaling pathway may partly play a role in the development of conventional RCC.
Y S Kim; Y K Kang; J B Kim; S A Han; K I Kim; S R Paik
Related Documents :
9050006 - Expression of beta 2-adrenoceptors in halobacteria.
11098056 - Transforming growth factor-beta 1-mediated inhibition of the flk-1/kdr gene is mediated...
14595746 - Cadherins, catenins and apc in pleural malignant mesothelioma.
10607566 - Cross-regulation of beta-catenin-lef/tcf and retinoid signaling pathways.
19549096 - Daytime gating in the syrian hamster pineal gland.
7478266 - Cellular distribution of the mrna for the kappa-opioid receptor in the human neocortex:...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pathology international     Volume:  50     ISSN:  1320-5463     ISO Abbreviation:  Pathol. Int.     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2000-11-06     Completed Date:  2000-11-16     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  9431380     Medline TA:  Pathol Int     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  725-30     Citation Subset:  IM    
Department of Pathology, College of Medicine, Korea University, Gojan-Dong, Ansan, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenocarcinoma / genetics,  metabolism,  pathology
Carcinoma, Papillary / genetics,  metabolism,  pathology
Carcinoma, Renal Cell / genetics*,  metabolism,  pathology
Cytoskeletal Proteins / biosynthesis,  genetics*
DNA Mutational Analysis
DNA Primers / chemistry
DNA, Neoplasm* / analysis
Immunoenzyme Techniques
Kidney / metabolism,  pathology
Kidney Neoplasms / genetics*,  metabolism,  pathology
Middle Aged
Mutation, Missense
Neoplasm Staging
Polymerase Chain Reaction
Polymorphism, Single-Stranded Conformational
beta Catenin
Reg. No./Substance:
0/CTNNB1 protein, human; 0/Cytoskeletal Proteins; 0/DNA Primers; 0/DNA, Neoplasm; 0/Trans-Activators; 0/beta Catenin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Correlation of tumor markers p53, bcl-2 and cathepsin-D with clinicopathologic features and disease-...
Next Document:  Angiomatoid (malignant) fibrous histiocytoma: a peculiar low-grade tumor showing immunophenotypic he...